Court ruling favors GenSpera in U.S. patent dispute


Court ruling favors GenSpera in U.S. patent dispute

By Peggy O’Hare
http://www.mysanantonio.com/ 
http://stockpumpers.blogspot.com/2014/11/court-ruling-favors-genspera-in-us.html
 SAN ANTONIO — A San Antonio company developing prodrug therapeutics to treat cancer said Thursday that a federal court ruled in its favor in a patent dispute.

GenSpera Inc. said it welcomed the Sept. 12 decision by a U.S. District Court in Maryland, which essentially dismisses Dr. Annastasiah Mhaka’s claims that she was wrongly omitted from two of the company’s U.S. patents for its lead drug candidate, mipsagargin.

Mhaka had worked as a post-graduate student for two of GenSpera’s founders who obtained the patents, Johns Hopkins University professors Samuel Denmeade and John Isaacs. Mhaka claimed she should have been credited as a co-inventor of the pharmaceutical. The company denied that.
“Our defense against these claims has demonstrated GenSpera’s commitment to protecting its technologies and intellectual property portfolio,” CEO Craig Dionne said.

About GenSpera
GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera’s lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. Mipsagargin is expected to have potential efficacy in a wide variety of tumor types.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s